Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-17-004226
Filing Date
2017-08-28
Accepted
2017-08-28 21:07:15
Documents
2
Period of Report
2017-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 20082
2 POWER OF ATTORNEY doc1.htm EX-24 3859
  Complete submission text file 0001477932-17-004226.txt   25519
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Mazur Leonard L (Reporting) CIK: 0001463414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 171055960

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations